UAB Health System CEO leaves for Memorial Sloan Kettering Cancer Center in New York

0

CARLA: THE BREAKING NEWS IS COMING OUT OF BIRMINGHAM WHERE THE UAV HEALTH SYSTEM LOSES ITS LEADER. THE CHIEF EXECUTIVE OFFICER HAS BEEN APPOINTED PRESIDENT AND CHIEF EXECUTIVE OFFICER OF — HE IS SCHEDULED TO START THIS NEW JOB IN SEPTEMBER AND WE ARE WORKING TO GET MO

UAB Health System CEO leaves for Memorial Sloan Kettering Cancer Center in New York

UAB Health System CEO Dr. Selwyn Vickers has been named the new president and CEO of Memorial Sloan Kettering Cancer Center in New York City. Vickers, 62, of Demopolis, Alabama, is a world-renowned surgeon, pancreatic cancer researcher, pioneer in health disparities research and a member of the prestigious Academy Institute of Medicine. National Science. Vickers became Dean of the Heersink School of Medicine in 2013 and was named CEO of the UAB Health System and the UAB/Ascension St. Vincent’s Alliance in January 2022. He served as a member of the faculty of surgery at the UAB from 1994 to 2006. “For 135 years, MSK has set the standard for excellence in patient care and in the search for new cancer treatments and cures, and is arguably the world’s preeminent center for training the next generation of scientific and medical leaders,” Vickers said. “The Sloan Kettering Institute’s basic science programs have led the world in cancer science discovery and translational research, and I’m confident that MSK is well on its way to tackling the one of the world’s greatest threats to life, cancer. I am honored to have the opportunity to work with pioneering researchers and dedicated doctors, nurses and staff to build on MSK’s extraordinary legacy. led to its naming and benefited from the transformative growth of National Institutes of Health research, adding $100 million in new NIH funding. “Dr. Vickers is an extraordinary surgeon-scientist with a proven track record of leading complex academic medical centers, creating innovative academic and research programs, and strengthening clinical care,” said Scott Stuart, president of the Memorial Sloan Kettering Cancer Center Boards of Trustees and Governor Trustees.” Throughout his career, he has demonstrated a passion for unlocking cancer treatments and cures. Dr. Vickers is a charismatic and compassionate leader who is uniquely qualified to lead this great organization into the future.” Vickers, a board-certified surgeon and past president of the American Surgical Association, completed his professional and surgical training at Johns Hopkins University School of Medicine and Hospital, including a senior residency and fellowship in surgical oncology.

UAB Health System CEO Dr. Selwyn Vickers has been named the new president and CEO of Memorial Sloan Kettering Cancer Center in New York City.

Vickers, 62, of Demopolis, Alabama, is a world-renowned surgeon, pancreatic cancer researcher, pioneer in health disparities research and a member of the prestigious Academy Institute of Medicine. National Science. Vickers became Dean of the Heersink School of Medicine in 2013 and was named CEO of the UAB Health System and the UAB/Ascension St. Vincent Alliance in January 2022. He served as a member of the UAB Faculty of Surgery from 1994 to 2006.

“For 135 years, MSK has set the standard of excellence in patient care and in the search for new cancer treatments and cures, and is arguably the world’s preeminent center for training the next generation of scientific and medical leaders,” Vickers said. “The Sloan Kettering Institute’s basic science programs have led the world in cancer science discovery and translational research, and I’m confident that MSK is well on its way to tackling the one of the world’s greatest threats to life, cancer. I am honored to have the opportunity to work with pioneering researchers and dedicated doctors, nurses and staff to build on MSK’s extraordinary legacy.

Under Vickers’ leadership, the Heersink School of Medicine has experienced significant growth, supported by a $95 million gift that led to its naming, and benefited from the transformative research growth of the National Institutes of Health, adding $100 million in new NIH funding.

“Dr. Vickers is an extraordinary surgeon-scientist with a proven track record of leading complex academic medical centers, creating innovative academic and research programs, and strengthening clinical care,” said Scott Stuart, president of the Memorial Sloan Kettering Cancer Center Boards of Trustees and Governor Trustees.” Throughout his career, he has demonstrated a passion for unlocking cancer treatments and cures. Dr. Vickers is a charismatic and compassionate leader who is uniquely qualified to guide this great organization into the future.”

Vickers, a board-certified surgeon and past president of the American Surgical Association, completed professional and surgical training at Johns Hopkins University School of Medicine and Hospital, including a chief residency and fellowship in surgical oncology.

Share.

About Author

Comments are closed.